← Back to Clinical Trials
Recruiting NCT07290231

NCT07290231 Effects of Core Strengthening Exercises With Diapgragmatic Breathing Versus Core Strengthening Exercises With Pilate Breathing in Diabetes Type II Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07290231
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Diabetes Type II
Study Type INTERVENTIONAL
Enrollment 56 participants
Start Date 2025-08-06
Primary Completion 2026-01-03

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
Core Strengthening with Diaphragmatic Breathingcore strengthening with pilate breathing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 56 participants in total. It began in 2025-08-06 with a primary completion date of 2026-01-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Diabetes type II is a metabolic syndrome involving high sugar levels known as hyperglycemia. It can impair pulmonary function through reduced lung elasticity and gas exchange and weaken core muscles due to inflammation and muscle atrophy. Literature has shown the individual effects of these exercises on quality of life. However, no study has yet evaluated the combined effects of these exercises on different variables such as lung function, functional capacity, and blood sugar levels. OBJECTIVE: The objective of this study is to compare the effects of diaphragmatic breathing and Pilates breathing, combined with core strengthening exercises, on lung function, functional capacity, blood sugar levels, and quality of life. The study aims to determine which breathing technique provides greater physiological and functional benefits. METHOD: The study will be a Randomized control trial consisting of two groups subjects meeting the inclusion criteria will be selected for the study. The subjects will then be randomly assigned to two groups. One group will receive Diaphragmatic breathing with core strengthening exercises and other group will receive Pilate breathing with core strengthening exercises. Before initiating the treatment procedure following would be assessed for all the patients: Pulmonary Function, Functional Capacity, Blood sugar levels and quality of life. Afterwards a treatment regime distributed over the course of six weeks will be given to all patients. After the interventions Pulmonary function, Functional capacity, Blood sugar levels and Quality of life would be reassessed. Data would be analyzed to evaluate the outcomes. DATA COLLECTION PROCEDURE: The participants eligible for the study according to inclusion and exclusion criteria would be recruited for the study voluntarily and referred from Medical OPD of Fauji Foundation Hospital and Rehab OPD of Fauji Foundation Hospital. The purpose of this study along with the treatment plan would be explained to the participants in the language they understand their best and informed consent will be taken from the participants. A treatment regimen consisting of 18 weeks distributed over the course of six weeks will be provided to the patients in multidisciplinary lab of foundation University College of physical therapy

Eligibility Criteria

Inclusion Criteria: * Medically diagnosed patients with Type II diabetes confirmed by a medical specialist, general practitioner, or endocrinologist from FFH or private hospital settings in Rawalpindi and Islamabad. * Age between 30 and 55 years. * Both male and female patients. * Willingness to participate in the exercise program and ability to provide informed consent. * On a stable regimen of anti-diabetic medications for at least three months prior to the study. Exclusion Criteria: * Patients with Type I diabetes, diabetes insipidus, or gestational diabetes. * Diagnosed chronic respiratory diseases such as COPD or asthma unrelated to diabetes. * History of any abdominal, orthopedic, or spinal surgery that could interfere with balance. * Uncontrolled cardiovascular conditions such as arrhythmias or recent myocardial infarction. * Morbid obesity (BMI \> 40). * Pregnant women.

Contact & Investigator

Central Contact

kinza Maqbool, DPT

✉ kinzamaqbool88@gmail.com

📞 03077493722

Frequently Asked Questions

Who can join the NCT07290231 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, up to 55 Years, studying Diabetes Type II. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07290231 currently recruiting?

Yes, NCT07290231 is actively recruiting participants. Contact the research team at kinzamaqbool88@gmail.com for enrollment information.

Where is the NCT07290231 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07290231 clinical trial?

NCT07290231 is sponsored by Foundation University Islamabad. The trial plans to enroll 56 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology